Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q4 2018 (← Previous) (Next →)
Filing Date: Feb 14, 2019
Total Value: $765M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CHEMOCENTRYX INC | 6,687,523 | $72.96M | 9.5% | — | — | COM | 16383L106 |
| — | ARRAY BIOPHARMA INC | 4,744,062 | $67.6M | 8.8% | — | — | COM | 04269X105 |
| — | MERUS N V | 4,514,913 | $63.21M | 8.3% | — | — | COM | N5749R100 |
| KURA | KURA ONCOLOGY INC | 2,775,156 | $38.96M | 5.1% | — | — | COM | 50127T109 |
| — | BLUEPRINT MEDICINES CORP | 574,967 | $31M | 4.1% | — | — | COM | 09627Y109 |
| — | MIRATI THERAPEUTICS INC | 688,851 | $29.22M | 3.8% | — | — | COM | 60468T105 |
| CYTK | CYTOKINETICS INC | 4,150,639 | $26.23M | 3.4% | — | — | COM NEW | 23282W605 |
| RCUS | ARCUS BIOSCIENCES INC | 2,411,623 | $25.97M | 3.4% | — | — | COM | 03969F109 |
| — | FIVE PRIME THERAPEUTICS INC | 2,781,346 | $25.87M | 3.4% | — | — | COM | 33830X104 |
| XOMA | XOMA CORP DEL | 1,769,029 | $22.38M | 2.9% | — | — | COM NEW | 98419J206 |
| XNCR | XENCOR INC | 593,465 | $21.46M | 2.8% | — | — | COM | 98401F105 |
| ACIU | AC IMMUNE SA | 2,230,027 | $21.07M | 2.8% | — | — | SHS | H00263105 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 17,426,968 | $20.56M | 2.7% | — | — | COM | 45665G303 |
| — | PIERIS PHARMACEUTICALS INC | 7,457,921 | $19.84M | 2.6% | — | — | COM | 720795103 |
| — | ARQULE INC | 6,230,418 | $17.26M | 2.3% | — | — | COM | 04269E107 |
| — | CONCERT PHARMACEUTICALS INC | 1,150,445 | $14.44M | 1.9% | — | — | COM | 206022105 |
| ANAB | ANAPTYSBIO INC | 220,265 | $14.05M | 1.8% | — | — | COM | 032724106 |
| — | MOLECULAR TEMPLATES INC | 3,364,421 | $13.59M | 1.8% | — | — | COM | 608550109 |
| — | CALITHERA BIOSCIENCES INC | 3,298,282 | $13.23M | 1.7% | — | — | COM | 13089P101 |
| — | DICERNA PHARMACEUTICALS INC | 1,215,727 | $13M | 1.7% | — | — | COM | 253031108 |
| — | GALMED PHARMACEUTICALS LTD | 1,878,508 | $12.83M | 1.7% | — | — | SHS | M47238106 |
| — | VERASTEM INC | 3,513,994 | $11.81M | 1.5% | — | — | COM | 92337C104 |
| — | BIOLINERX LTD | 25,995,575 | $11.37M | 1.5% | — | — | SPONSORED ADS | 09071M106 |
| XENE | XENON PHARMACEUTICALS INC | 1,788,774 | $11.29M | 1.5% | — | — | COM | 98420N105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,639,458 | $11.03M | 1.4% | — | — | COM | 74366E102 |
| — | SPRING BK PHARMACEUTICALS INC | 951,701 | $9.888M | 1.3% | — | — | COM | 849431101 |
| REPL | REPLIMUNE GROUP INC | 899,617 | $8.996M | 1.2% | — | — | COM | 76029N106 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,987,669 | $8.845M | 1.2% | — | — | COM | 87164F105 |
| — | VBI VACCINES INC | 5,216,857 | $8.347M | 1.1% | — | — | COM NEW | 91822J103 |
| — | MEI PHARMA INC | 2,978,708 | $7.864M | 1.0% | — | — | COM NEW | 55279B202 |
| ARGX | ARGENX SE | 80,868 | $7.769M | 1.0% | — | — | SPONSORED ADR | 04016X101 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,890,507 | $6.938M | 0.9% | — | — | COM | 221015100 |
| — | EIGER BIOPHARMACEUTICALS INC | 675,000 | $6.858M | 0.9% | — | — | COM | 28249U105 |
| — | CIDARA THERAPEUTICS INC | 2,904,684 | $6.826M | 0.9% | — | — | COM | 171757107 |
| — | IMMUNE DESIGN CORP | 5,185,383 | $6.741M | 0.9% | — | — | COM | 45252L103 |
| — | FORWARD PHARMA A/S | 8,480,079 | $6.614M | 0.9% | — | — | SPONSORED ADR | 34986J105 |
| SPRO | SPERO THERAPEUTICS INC | 843,146 | $5.185M | 0.7% | — | — | COM | 84833T103 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $5.084M | 0.7% | — | — | COM NEW | 12648L601 |
| KALV | KALVISTA PHARMACEUTICALS INC | 252,693 | $4.991M | 0.7% | — | — | COM | 483497103 |
| — | ALBIREO PHARMA INC | 200,500 | $4.918M | 0.6% | — | — | COM | 01345P106 |
| — | ERYTECH PHARMA | 625,000 | $4.234M | 0.6% | — | — | SPONSORED ADR | 29604W108 |
| — | PRINCIPIA BIOPHARMA INC | 146,300 | $4.007M | 0.5% | — | — | COM | 74257L108 |
| — | ONCOMED PHARMACEUTICALS INC | 4,042,989 | $3.021M | 0.4% | — | — | COM | 68234X102 |
| — | CONTRAFECT CORP | 1,898,990 | $2.905M | 0.4% | — | — | COM | 212326102 |
| — | MERRIMACK PHARMACEUTICALS INC | 721,935 | $2.787M | 0.4% | — | — | COM NEW | 590328209 |
| — | ALPINE IMMUNE SCIENCES INC | 643,059 | $2.366M | 0.3% | — | — | COM | 02083G100 |
| — | SURFACE ONCOLOGY INC | 451,850 | $1.916M | 0.3% | — | — | COM | 86877M209 |
| — | VICAL INC | 1,285,848 | $1.517M | 0.2% | — | — | COM NEW | 925602203 |
| — | GENOCEA BIOSCIENCES INC | 5,114,455 | $1.467M | 0.2% | — | — | COM | 372427104 |
| — | ESSA PHARMA INC | 580,368 | $1.219M | 0.2% | — | — | COM NEW | 29668H708 |
| — | REGULUS THERAPEUTICS INC | 1,051,940 | $979K | 0.1% | — | — | COM NEW | 75915K200 |
| — | SUNESIS PHARMACEUTICALS INC | 2,287,860 | $951K | 0.1% | — | — | COM PAR | 867328700 |
| — | REALM THERAPEUTICS PLC | 360,866 | $668K | 0.1% | — | — | SPONSORED ADS | 75606L103 |
| — | LOXO ONCOLOGY INC | 3,944 | $552K | 0.1% | — | — | COM | 548862101 |
| IONS | IONIS PHARMACEUTICALS INC | 9,399 | $508K | 0.1% | — | — | COM | 462222100 |